Immunohistochemical biomarkers for bladder cancer prognosis.
about
New and contemporary markers of prognosis in nonmuscle invasive urothelial cancerCD24 expression is important in male urothelial tumorigenesis and metastasis in mice and is androgen regulated.High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer.Initiation and termination of DNA replication during S phase in relation to cyclins D1, E and A, p21WAF1, Cdt1 and the p12 subunit of DNA polymerase δ revealed in individual cells by cytometryIdentification of γ-synuclein as a stage-specific marker in bladder cancer by immunohistochemistry.Expression of the p12 subunit of human DNA polymerase δ (Pol δ), CDK inhibitor p21(WAF1), Cdt1, cyclin A, PCNA and Ki-67 in relation to DNA replication in individual cellsProfilin 1 is a potential biomarker for bladder cancer aggressivenessBladder cancer: a simple model becomes complex.A diagnostic marker for superficial urothelial bladder carcinoma: lack of nuclear ATBF1 (ZFHX3) by immunohistochemistry suggests malignant progression.Immunohistochemical evaluation of cell cycle regulators: impact on predicting prognosis in stage t1 urinary bladder cancer.Lower cyclooxygenase-2 expression is associated with recurrence of solitary non-muscle invasive bladder carcinomaUBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy.Roles of Signal Transducer Pathways in Investigation of Biopsies from Patients with Bladder Tumors
P2860
Q26798006-6CB5CD6F-B307-4559-ABE1-D08CBD241084Q30418726-1BC56058-945B-4C71-9369-FFC845307C30Q34184763-4EDB8FD4-87C7-4D9B-869C-29594438A3C9Q34480026-0E5E816A-676D-428A-BBE6-672C6F3FFBEEQ34700572-0BDA6E81-F0CA-487E-AE41-807E5ABF410DQ35497978-DFACC686-7BB1-4D47-B0A3-B0BAFB9EB898Q35878733-B4C59A1A-AF9B-48E1-97FA-9F84034B436DQ36108115-7C07A2D7-AE85-4394-B6A3-8370BB0F02F5Q36166662-7F6333E1-901B-474E-8FBE-A7E9AF6F32FDQ36470349-EE3F6AA4-8A58-4E14-8ACC-F12278828BE1Q36480350-7BA81958-F2B5-4116-94DC-70785416569FQ36956211-35E3A4BB-EB84-4262-BF9F-5340009F3D68Q41461442-A5A28E2A-BBE1-4190-BD52-B08F50DB7D28
P2860
Immunohistochemical biomarkers for bladder cancer prognosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunohistochemical biomarkers for bladder cancer prognosis.
@en
Immunohistochemical biomarkers for bladder cancer prognosis.
@nl
type
label
Immunohistochemical biomarkers for bladder cancer prognosis.
@en
Immunohistochemical biomarkers for bladder cancer prognosis.
@nl
prefLabel
Immunohistochemical biomarkers for bladder cancer prognosis.
@en
Immunohistochemical biomarkers for bladder cancer prognosis.
@nl
P2093
P2860
P1476
Immunohistochemical biomarkers for bladder cancer prognosis.
@en
P2093
Douglas S Scherr
Harun Fajkovic
Kazuhito Matsushita
Kazumasa Matsumoto
Maxine Sun
Pierre I Karakiewicz
Shahrokh F Shariat
Shiro Baba
Thomas F Chromecki
P2860
P304
P356
10.1111/J.1442-2042.2011.02809.X
P577
2011-07-20T00:00:00Z